Jasper Therapeutics, Inc.
JSPR
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 1,108.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | -1,108.00 | 0.00 | 0.00 | 0.00 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 51,785.00 | 34,627.00 | 25,421.00 | 15,883.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 17,076.00 | 16,569.00 | 11,412.00 | 4,800.00 | |
| Depreciation & Amortization | 1,011.00 | 1,373.00 | 1,108.00 | -12,925.00 | -6,276.00 | 10,875.00 | |
| Total Operating Expenses | 93,329.00 | 76,239.00 | 68,861.00 | 51,196.00 | 36,833.00 | 20,683.00 | |
| Operating Income | -93,329.00 | -76,239.00 | -68,861.00 | -51,196.00 | -36,833.00 | -20,683.00 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 2,341.00 | 5,058.00 | 5,199.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | -13,511.00 | 0.00 | 0.00 | |
| Other Expense | 2,308.00 | 4,970.00 | 2,768.00 | 13,511.00 | 6,196.00 | -10,986.00 | |
| IBT | -91,021.00 | -71,269.00 | -66,093.00 | -37,685.00 | -30,637.00 | -31,669.00 | |
| Income Tax Expense | 0.00 | 0.00 | -1,628.00 | -13,511.00 | -6,653.00 | -38.45 | |
| Net Income | -91,021.00 | -71,269.00 | -64,465.00 | -24,174.00 | -23,984.00 | -31,669.00 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-6.18 | $-6.63 | $-21.05 | $-114.30 | |
| EPS Diluted | $0.00 | $0.00 | $-6.18 | $-6.63 | $-21.05 | $-114.30 | |
| Shares Outstanding | 16,580.00 | 14,584.00 | 10,439.00 | 3,648.28 | 1,139.38 | 277.07 | |
| Diluted Shares Outstanding | 16,635.78 | 14,584.87 | 10,439.03 | 3,648.28 | 1,139.38 | 277.07 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -62,436.00 | -71,269.00 | -64,465.00 | -37,685.00 | -30,637.00 | -31,669.00 | |
| Depreciation & Amortization | 1,146.00 | 1,373.00 | 1,108.00 | 975.00 | 377.00 | 0.00 | |
| Stock-Based Compensation | 5,204.00 | 6,619.00 | 5,211.00 | 4,091.00 | 1,048.00 | 1,210.00 | |
| Change Working Capital | 98.00 | 173.00 | 5,103.00 | -649.00 | 1,621.00 | 1,296.00 | |
| Change In Accounts Receivable | -663.00 | 0.00 | 663.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 1,267.00 | -122.00 | 2,381.00 | -2,151.00 | 2,938.00 | 358.00 | |
| Change In Inventories | -283.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 6,069.00 | 502.00 | 976.00 | -12,590.00 | -9,088.00 | 10,896.00 | |
| Cash from Operations | -55,876.00 | 0.00 | -52,067.00 | -45,858.00 | -33,678.00 | -18,267.00 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | -412.00 | -552.00 | -267.00 | -576.00 | -2,428.00 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 198.34 | |
| Cash from Investing | -412.00 | 0.00 | -267.00 | -576.00 | -2,428.00 | 198.34 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | -918.00 | -973.00 | -865.00 | 766.00 | 1,261.00 | 1,624.00 | |
| Issuance of Common Stock | 47,594.00 | 0.00 | 101,479.00 | 27.00 | 10,750.00 | 0.00 | |
| Repurchase of Common Stock | -0.30 | 0.00 | 0.00 | 28.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -144.78 | 0.00 | -508.00 | 0.00 | 90,219.00 | 0.00 | |
| Cash from Financing | 47,295.00 | 0.00 | 100,971.00 | 55.00 | 100,969.00 | 11,287.00 | |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Change in Cash | -8,993.00 | -15,250.00 | 48,637.00 | -46,379.00 | 64,863.00 | -6,980.00 | |
| Closing Cash Balance | 106,819.00 | 72,054.00 | 87,304.00 | 38,667.00 | 85,046.00 | 20,183.00 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -56,288.00 | -63,154.00 | -52,334.00 | -46,434.00 | -36,106.00 | -18,267.00 | |
| Real Free Cash Flow | -61,492.00 | -69,773.00 | -57,545.00 | -50,525.00 | -37,154.00 | -19,477.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
